• Product

  • Technology

  • About AIVIS

Smart AI Quantification
for Precision Medicine

/images/main/main-graphic-1.webp
/images/main/main-graphic-2.svg

Rapid, Reliable and Robust IHC Quantification for Precision Medicine

Qanti® IHC

Pathologists & Clinicians

Quantification for clinically useful IHC expression

Breast
ER/PR
HER2
Ki-67
NET
Ki-67
Thyroid
Ki-67
Gastric
HER2

Qanti® Discovery

Pharmaceutical companies & Researchers

Quantification for novel drug target IHC expression

Membrane
Necleus
CytoplasmUpcoming

Recent Publications

A Standardized Validation Framework of Ki-67 Digital Image Analysis Using a Public Dataset in Breast Cancer
ESMO Breast Cancer 2026

A Standardized Validation Framework of Ki-67 Digital Image Analysis Using a Public Dataset in Breast Cancer

May 6, 2026
AI-Based Quantification of Central Tumor-Infiltrating Lymphocytes to Predict Recurrence-Free Survival in Bladder Cancer TURB Specimens
USCAP 2026

AI-Based Quantification of Central Tumor-Infiltrating Lymphocytes to Predict Recurrence-Free Survival in Bladder Cancer TURB Specimens

March 21, 2026
Detection of Residual Tumor Cells in H&E Slides for Breast Cancer After Neoadjuvant Chemotherapy Using an IHC-trained AI Model
USCAP 2026

Detection of Residual Tumor Cells in H&E Slides for Breast Cancer After Neoadjuvant Chemotherapy Using an IHC-trained AI Model

March 21, 2026

Our Clients & Partners

Our Clients

Business Partners

Research Partners

Latest News

AIVIS Presents Two Studies Advancing Pathology AI for Real-World Clinical Use at International Conferences

AIVIS Presents Two Studies Advancing Pathology AI for Real-World Clinical Use at International Conferences

November 13, 2026
etnews
AIVIS Presents Breast Cancer Biomarker Ki-67 Digital Pathology AI Validation Study at ESMO Breast Cancer 2026

AIVIS Presents Breast Cancer Biomarker Ki-67 Digital Pathology AI Validation Study at ESMO Breast Cancer 2026

May 11, 2026
etnews
AIVIS Selected for Government’s "DIPS 1000+" Deep Tech Project to Advance ADC Biomarker Quantification

AIVIS Selected for Government’s "DIPS 1000+" Deep Tech Project to Advance ADC Biomarker Quantification

April 21, 2026
etnews

For more information

banner

Copyright © AIVIS Inc. 2026

CONTACT

help@aivis.kr

+82-2-6378-2021

ADDRESS

6th & 8th floor, 238, Teheran-ro, Gangnam-gu, Seoul, Republic of Korea

PRODUCT

Qanti® Overview

Qanti® Breast ER/PR

Qanti® Breast HER2

Qanti® Breast Ki-67

Qanti® NET Ki-67

Qanti® Thyroid Ki-67

Qanti® Gastric HER2

Qanti® Discovery

EXPLORE

Certification

Publication

Patent

News & Events

About Us

Recruiting

Privacy Policy